Official data reveals that the 2024–2025 period marked a historic peak in global trade remedy actions targeting Chinese exports, reflecting an unprecedented level of international scrutiny. At the same time, a steady decline in China-initiated investigations challenges the prevailing perception that Beijing typically responds to foreign trade remedies with its own, suggesting a more selective approach to trade remedy usage by China.